| Name | Title | Contact Details |
|---|
DiagnoCure (TSX: CUR; OTCQX: DGCRF) is a life sciences corporation that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, the Corporation launched a colorectal cancer staging test through its U.S. CLIA laboratory. PrevistageTM GCC is currently available for licensing. The Corporation has granted a worldwide exclusive license on the diagnostic applications of its proprietary molecular biomarker PCA3 to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. Hologic Gen-Probe's PROGENSA® PCA3 prostate cancer test is commercialized in Europe under CE mark and is approved for commercialization in Canada and the United States.
Touchstone Health Partnership is a White Plains, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Dufort et Lavigne is a Montreal-Est, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
AlloSource is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Centennial, CO. To find more information about AlloSource, please visit www.allosource.org
Altheus Therapeutics is a Oklahoma City, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.